Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. (2012)

First Author: Nair P
Attributed to:  Wessex severe asthma cohort funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/j.1365-2222.2012.04014.x

PubMed Identifier: 22702508

Publication URI: http://europepmc.org/abstract/MED/22702508

Type: Journal Article/Review

Volume: 42

Parent Publication: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Issue: 7

ISSN: 0954-7894